🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
antiperistaltic effect and safety of L-menthol versus placebo for upper GI ...
Status
Unknown
Location
Taipei Veterans General Hospital
Start Date
2012-03
Trial ID
NCT04593836
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
A Randomized Phase II Study to Evaluate the Incidence of Discontinuations d...
Status
Active Not Recruiting
Location
Hospital General Universitario de Elche
Start Date
2022-08-31
Trial ID
NCT05252988
Treatments Being Tested
PRIMARY: To assess the effect of bovine anti-Cryptosporidium immunoglobulin...
Status
Completed
Location
Gabin Med Group
Start Date
TBD
Trial ID
NCT00002248
Treatments Being Tested
Billroth-II (gastrojejunostomy) is one of major option after gastrectomy fo...
Status
Unknown
Location
Keimyung University Dongsan Medical Center
Start Date
2016-03
Trial ID
NCT02837874
Treatments Being Tested
Postoperative gastroesophageal reflux is one of the most common complicatio...
Status
Unknown
Location
Multiple Locations
Start Date
2018-01-01
Trial ID
NCT03372681
Researchers want to learn if sacituzumab tirumotecan (MK-2870) alone or wit...
Status
Recruiting
Location
UCLA ( Site 0317)
Start Date
2024-06-20
Trial ID
NCT06428409
This study aims to investigate the effects of intracorporeal anastomosis an...
Status
Active Not Recruiting
Location
the First Hospital of Jilin University
Start Date
2021-01-27
Trial ID
NCT04201717
Background: The new drug LMP744 (NSC 706744) damages deoxyribonucleic acid...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-02-27
Trial ID
NCT03030417